¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀå´ë»çÁõÈıºÇÐȸ 2020 Ãß°è½ÉÆ÷Áö¾ö : 2020-09-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
½ÉÀå´ë»çÁõÈıºÇÐȸ 2020 Ãß°è½ÉÆ÷Áö¾ö : 2020-09-19
±³À°ÀÏÀÚ : 2020-09-19
±³À°Àå¼Ò : ½ºÀ§½º±×·£µåÈ£ÅÚ ¿¡¸Þ¶öµåȦ A  
±³À°ÁÖÁ¦ : ½ÉÀå´ë»çÁõÈıºÇÐȸ 2020 Ãß°è½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ  
´ã´çÀÚ : ÀÌÈ¿Áø 
¿¬¶ôó : 032-460-3663  
À̸ÞÀÏ : secret9595@naver.com      
±³À°Á¾·ù : ³»°ú¿¹¹æÀÇÇÐ, ÀÇÇб³À°,      
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã 
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í ±³¼ö ¹× °³¿øÀÇ 4¸¸ / Àü°øÀÇ,ÀüÀÓÀÇ, ±âŸ 2¸¸      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 09:00~09:15 Trends in CardioMetabolic Syndrome in Korea  Á¶µ¿Çõ(¿¬¼¼ÀÇ´ë ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 09:15~09:30 Contemporary Lipidology Bench to Bedside  Àü¼º¿Ï(¼øõÇâÀÇ´ë õ¾Èº´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 09:30~09:45 Obesity and Cardiometabolic Syndrome  ±ÇÇõ»ó(°¡Å縯ÀÇ´ë ¿©Àǵµ¼º¸ðº´¿ø) 
Åä·Ð 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 09:45~10:05 Discussion  All Panellist() 
È޽Ġ09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 10:05~10:35 Coffee Break  () 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 10:35~10:50 Gender Difference in CardioMetabolic Syndrome  ±èÇзÉ(¼­¿ïÀÇ´ë º¸¶ó¸Åº´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 10:50~11:05 Obesity in Women  ±èÇöÁø(ÇѾçÀÇ´ë ±¸¸®º´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 11:05~11:20 Diabetes and Insulin Resistance, Gender Aspect  ±è¹Ì³ª(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 11:20~11:35 Sex/Gender Difference in Coronary Artery Disease  ¹Ú»ó¹Î(À»ÁöÀÇ´ë ³ë¿øÀ»Áöº´¿ø) 
Åä·Ð 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 11:35~11:55 Discussion  All Panellist() 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 11:55~12:10 Appropriate Treatment of Dyslipidemia for Primary Prevention  ÀÓ¼ö(¼­¿ïÀÇ´ë ºÐ´ç¼­¿ï´ëº´¿ø) 
½Ä»ç 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦB 12:10~13:10 Lunch  () 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 13:10~13:25 Mitophagy in the Pathogenesis of Cardiovascular Disease  ¿À±¸ÅÃ(ÀÌÈ­¿©´ë »ý¸í°úÇаú) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 13:25~13:40 Dysglycemia, Glucose Variability and Diastolic Dysfunction  Áø»ó¸¸(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 13:40~13:55 Sarcopenia and Cardiovascular Disease  ÀüÁöÀº(°æÈñÀÇ´ë °­µ¿°æÈñ´ëº´¿ø) 
Åä·Ð 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 13:55~14:15 Discussion  All Panellist() 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 14:15~14:30 SGLT-2 Inhibitors for Metabolic Abnormalities  ¹®Áؼº(¿µ³²ÀÇ´ë ¿µ³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 14:30~14:45 SGLT-2 Inhibitors for Heart Failure  À¯º´¼ö(¿¬¼¼ÀÇ´ë ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 14:45~15:00 Pleiotropic Effects of GLP-1 Analogues  È«ÁØÈ­(À»ÁöÀÇ´ë ´ëÀüÀ»Áöº´¿ø) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 15:00~15:15 Statin + Omega-3 Fatty Acids vs. Statin + Fibrate  Á¶»óÈ£(ÇѸ²ÀÇ´ë ¼º½Éº´¿ø) 
Åä·Ð 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 15:15~15:35 Discussion  All Panellist() 
È޽Ġ09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 15:35~15:55 Coffee Break  () 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 15:55~16:10 Dietary Risks and Cardiometabolic Disease: Findings from KNHANES '2005-2017'  ½Å¹ÎÁ¤(°í·Á´ë º¸°Ç°úÇдëÇÐ) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 16:10~16:25 Is Too Much Exercise Bad for Your Heart?  Á¦¼¼¿µ(¼­¿ï½Ã¸³´ë ¿¹¼úüÀ°´ëÇÐ) 
±³À°½Ã°£ 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 16:25~16:40 Application of Risk Engine in Predicting Cardiometabolic Syndrome  ¹èÀçÇö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø) 
Åä·Ð 09¿ù 19ÀÏ ¿¡¸Þ¶öµåȦA 16:40~17:00 Discussion  All Panellist() 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀå´ë»çÁõÈıºÇÐȸ 2020 Ãß°è½ÉÆ÷Áö¾ö : 2020-09-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ïƯº°½ÃÀÇ»çȸ (¿Â¶óÀÎ) Á¦14ȸ °­³²4°³±¸ÀÇ»çȸ ¿Â¶óÀÎ ÇÕµ¿Çмú´ëȸ : 2020-09-19
´ÙÀ½±Û ´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 56 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 38 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 39 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 51 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 40 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 36 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 13 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 14 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 33 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 16 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 15 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 35 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 26 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 30 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 24 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷